[1] |
ZHANG Chunhong, HUANG Hongchao, LIU Yue, DU Lilong, XU Haiwei, LI Ning, LI Yongjin.
Identification of key ferroptosis genes in paraspinal muscle degeneration based on RNA sequencing and bioinformatics analysis
[J]. Tianjin Medical Journal, 2024, 52(9): 991-995.
|
[2] |
WANG Xinshuang, AN Yajuan, GUAN Xiuju, LI Jiao, LIU Yue, WEI Liping, QI Xin.
Study of magnesium isoglycyrrhizinate in ameliorating cisplatin induced myocardial injury in rats
[J]. Tianjin Medical Journal, 2024, 52(8): 809-814.
|
[3] |
QIN Hanlin, HU Changlu, ZHAO Yamei, NIU Weina.
Effect and safety of quadruple regimen in preventing multi-day cisplatin-based chemotherapy induced nausea and vomiting
[J]. Tianjin Medical Journal, 2024, 52(8): 835-839.
|
[4] |
YUAN Man, FENG Zihan, XIE Min, WANG Bojun.
Mechanism of emodin modulating pain behavior in mouse model of osteoarthritis
[J]. Tianjin Medical Journal, 2024, 52(6): 572-577.
|
[5] |
WANG Aihua, ZHANG Feizhong, WANG Hongying.
Impacts of muscone on malignant progression of ovarian cancer cells by regulating SHH mediated autophagy
[J]. Tianjin Medical Journal, 2024, 52(2): 142-147.
|
[6] |
YU Ping, ZHOU Min, SU Dan.
Construction and validation of chemotherapy resistance prediction model for ovarian cancer
[J]. Tianjin Medical Journal, 2024, 52(11): 1177-1182.
|
[7] |
LI Shaoru, LI Yan, LIU Shan, HU Ruili.
Influences of lncRNA SNHG11 on proliferation, apoptosis, migration and invasion of ovarian cancer cells by regulating miR-184/CARM1 signaling axis
[J]. Tianjin Medical Journal, 2023, 51(6): 561-567.
|
[8] |
GENG Yongzhi, YANG Li, LI Guowei, ZHANG Jintao, CHENG Xiaolei, TAN Liduan.
Study on the improvement effect and mechanism of nobiletin on rats with acute kidney injury
[J]. Tianjin Medical Journal, 2023, 51(5): 498-503.
|
[9] |
LI Juan, NI Huihua.
Relationship between the expression of GPR120 and GPR40 and clinicopathological features and survival outcome of ovarian cancer patients
[J]. Tianjin Medical Journal, 2023, 51(5): 522-526.
|
[10] |
YI Wanping, MA Deshou.
High-intensity focused ultrasound enhances cisplatin chemotherapy sensitivity of breast cancer through TRIF-mediated ERK pathway
[J]. Tianjin Medical Journal, 2022, 50(7): 698-706.
|
[11] |
YU Kuiyang, LIU Pan, ZHANG Haowen, QIN Tao, HU Mingxing△.
Study on the mechanism of LncRNA ZFAS1 targeting miR-373 to induce cisplatin resistance in hepatocellular carcinoma cells
[J]. Tianjin Medical Journal, 2022, 50(5): 455-460.
|
[12] |
CHEN Xiao, WU Xiaoying, AN Ming.
Effects of lncRNA SOX21-AS1 expression on proliferation and metastasis of ovarian cancer cells and its mechanism
[J]. Tianjin Medical Journal, 2022, 50(12): 1254-1258.
|
[13] |
MA Zhi, WANG Xinshuang, LIU Yue, WEI Liping, QI Xin.
The protective mechanism of differential isomers of glycyrrhetinic acid on cisplatin-induced H9c2 cardiomyocyte injury
[J]. Tianjin Medical Journal, 2022, 50(12): 1264-1269.
|
[14] |
ZHANG Yimeng, ZHANG Yuxin, TIAN Faming.
The analysis and verification of osteoporosis associated hub genes and prediction of miRNA interactions
[J]. Tianjin Medical Journal, 2022, 50(11): 1158-1164.
|
[15] |
LI Shi-xiong, , GENG Hua, XU Mei-lin△.
Effects of long non-coding RNA BCYRN1 on the biological behavior of lung adenocarcinoma cells#br#
[J]. Tianjin Medical Journal, 2021, 49(9): 904-909.
|